December 10, 2020 09:00 - 10:15 ET
Life sciences have taken on increased importance in recent months, and are sure to be a significant part of Canada’s post-pandemic economy. Join us for our five-part webinar series that will discuss the latest legal and regulatory developments at all stages of the sector’s complex life cycle.
The pandemic has been a turning point for investment in life sciences. What does this mean for investors as well as life sciences companies looking to find opportunity in the industry? In the final webinar of our series, our corporate and capital markets lawyers from Toronto, New York and Calgary—Cheryl Reicin, Chris Bornhorst and Mike Pedlow—unpack the current state of financing for life science companies. The panel will discuss seed investments, venture capital, and public offerings both from Canadian and U.S. perspectives.
9:00 a.m. Webinar opens
9:15 - 10:15 a.m. Presentation
Ontario: This program is eligible for up to 1.0 Substantive hour.
New York: This program contains 1.0 Areas of Professional Practice Credit.
Sessions in this series: